Related Experiment Videos
Analysis of CD34-expressing cells in clinical practice
1Department of Haematology-Oncology, Campus Virchow Hospital Charite, Humboldt University, Berlin, Germany.
Vox Sanguinis
|August 15, 1998
Summary
Flow cytometry for CD34-expressing cells improves harvesting of circulating haemopoietic stem cells. This method now often replaces in-vitro culture tests for estimating haemopoietic potential before transplantation.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- High-dose chemotherapy and radiotherapy necessitate stem cell transplantation for patient recovery.
- Accurate assessment of haemopoietic stem cell (HSC) content is crucial for successful transplantation.
- Traditional methods for assessing HSCs, like CFU-GM assays, have limitations.
Purpose of the Study:
- To highlight the role of flow cytometry in quantifying CD34-expressing cells.
- To demonstrate the improvement in managing circulating haemopoietic stem cell harvesting.
- To discuss the replacement of in-vitro culture tests with flow cytometry for assessing haemopoietic potential.
Main Methods:
- Flow cytometry analysis to identify and quantify CD34-expressing cells.
- Comparison of flow cytometry data with traditional in-vitro culture tests (CFU-GM).
Main Results:
- Flow cytometry for CD34+ cells significantly enhances the management of circulating haemopoietic stem cell harvesting.
- This method provides a reliable measure of haemopoietic potential for autologous reinfusion.
- Flow cytometry has been adopted in some centers, replacing CFU-GM assays.
Conclusions:
- Flow cytometry determination of CD34+ cells is a valuable advancement in stem cell transplantation.
- It offers a more efficient and potentially more accurate method for assessing stem cell grafts.
- This technique improves patient management in high-dose chemo/(radio)-therapy settings.